These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 2571412

  • 1. Structure-activity studies of the nonphorbol tumor promoter palytoxin in Swiss 3T3 cells.
    Wattenberg EV, Uemura D, Byron KL, Villereal ML, Fujiki H, Rosner MR.
    Cancer Res; 1989 Nov 01; 49(21):5837-42. PubMed ID: 2571412
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Activation of stress-activator protein kinase/c-Jun N-terminal kinase by the non-TPA-type tumor promoter palytoxin.
    Kuroki DW, Bignami GS, Wattenberg EV.
    Cancer Res; 1996 Feb 01; 56(3):637-44. PubMed ID: 8564984
    [Abstract] [Full Text] [Related]

  • 4. Palytoxin down-modulates the epidermal growth factor receptor through a sodium-dependent pathway.
    Wattenberg EV, McNeil PL, Fujiki H, Rosner MR.
    J Biol Chem; 1989 Jan 05; 264(1):213-9. PubMed ID: 2562838
    [Abstract] [Full Text] [Related]

  • 5. Mitogen-activated protein kinases regulate palytoxin-induced calcium influx and cytotoxicity in cultured neurons.
    Vale C, Gómez-Limia B, Vieytes MR, Botana LM.
    Br J Pharmacol; 2007 Sep 05; 152(2):256-66. PubMed ID: 17641674
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of transformed foci and induction of prostaglandins in Balb/c 3T3 cells by palytoxin: in vitro model reproduces carcinogenic responses in animal models regarding the inhibitory effect of indomethacin and reversal of indomethacin's effect by exogenous prostaglandins.
    Miura D, Kobayashi M, Kakiuchi S, Kasahara Y, Kondo S.
    Toxicol Sci; 2006 Jan 05; 89(1):154-63. PubMed ID: 16192471
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mechanism of the cardiotoxic action of palytoxin.
    Frelin C, Vigne P, Breittmayer JP.
    Mol Pharmacol; 1990 Dec 05; 38(6):904-9. PubMed ID: 1979145
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mechanism of the excitatory action of palytoxin and N-acetylpalytoxin in the isolated guinea-pig vas deferens.
    Ohizumi Y, Shibata S.
    J Pharmacol Exp Ther; 1980 Jul 05; 214(1):209-12. PubMed ID: 6104716
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of palytoxin or ouabain on growth and squamous differentiation of human bronchial epithelial cells in vitro.
    Bonnard C, Lechner JF, Gerwin BI, Fujiki H, Harris CC.
    Carcinogenesis; 1988 Dec 05; 9(12):2245-9. PubMed ID: 2903801
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of palytoxin-induced depolarization in squid axons.
    Muramatsu I, Uemura D, Fujiwara M, Narahashi T.
    J Pharmacol Exp Ther; 1984 Dec 05; 231(3):488-94. PubMed ID: 6150105
    [Abstract] [Full Text] [Related]

  • 14. In vitro approaches to evaluate palytoxin-induced toxicity and cell death in intestinal cells.
    Valverde I, Lago J, Vieites JM, Cabado AG.
    J Appl Toxicol; 2008 Apr 05; 28(3):294-302. PubMed ID: 17604342
    [Abstract] [Full Text] [Related]

  • 15. Measurement of neutrophil activation and epidermal cell toxicity by palytoxin and 12-O-tetradecanoylphorbol-13-acetate.
    Gabrielson EW, Kuppusamy P, Povey AC, Zweier JL, Harris CC.
    Carcinogenesis; 1992 Sep 05; 13(9):1671-4. PubMed ID: 1356652
    [Abstract] [Full Text] [Related]

  • 16. Palytoxin induces K+ efflux from yeast cells expressing the mammalian sodium pump.
    Scheiner-Bobis G, Meyer zu Heringdorf D, Christ M, Habermann E.
    Mol Pharmacol; 1994 Jun 05; 45(6):1132-6. PubMed ID: 7912814
    [Abstract] [Full Text] [Related]

  • 17. Palytoxin-induced Na+ influx into yeast cells expressing the mammalian sodium pump is due to the formation of a channel within the enzyme.
    Redondo J, Fiedler B, Scheiner-Bobis G.
    Mol Pharmacol; 1996 Jan 05; 49(1):49-57. PubMed ID: 8569711
    [Abstract] [Full Text] [Related]

  • 18. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
    Showalter HD, Sercel AD, Leja BM, Wolfangel CD, Ambroso LA, Elliott WL, Fry DW, Kraker AJ, Howard CT, Lu GH, Moore CW, Nelson JM, Roberts BJ, Vincent PW, Denny WA, Thompson AM.
    J Med Chem; 1997 Feb 14; 40(4):413-26. PubMed ID: 9046331
    [Abstract] [Full Text] [Related]

  • 19. Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor.
    Smaill JB, Palmer BD, Rewcastle GW, Denny WA, McNamara DJ, Dobrusin EM, Bridges AJ, Zhou H, Showalter HD, Winters RT, Leopold WR, Fry DW, Nelson JM, Slintak V, Elliot WL, Roberts BJ, Vincent PW, Patmore SJ.
    J Med Chem; 1999 May 20; 42(10):1803-15. PubMed ID: 10346932
    [Abstract] [Full Text] [Related]

  • 20. Growth factors modify the epidermal growth factor receptor through multiple pathways.
    Friedman BA, Rosner MR.
    J Cell Biochem; 1987 May 20; 34(1):1-11. PubMed ID: 3584259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.